PharmiWeb.com - Global Pharma News & Resources
19-Oct-2018

D2 Consulting Publishes White Paper about Successful Value Based Contracting Strategies

D2 Consulting and partner Riparian today released a joint white paper expanding on the importance of aligning reimbursement to value rather than volume. The VBC blueprint offers strategies and guidance for successful negotiations that respond to changes resulting from regulatory and market pressures to reduce cost without compromising safety and quality. D2 is a leading life sciences consulting firm offering both strategic and tactical commercialization services to pharmaceutical, biotechnology and medical device manufacturers.

“While value based care with value based contracting is hailed as a solution to the challenges of affordability and sustainability in today’s marketplace, the operational complexity of implementing these types of arrangements, as well as the financial risks for manufacturers, must be carefully evaluated and navigated,” says Dean Erhardt, president and CEO, D2 Consulting. “Since this is not an assignment for tyros or novices, many companies simply shy away from the opportunity and forego meaningful revenues. The key to success lies in designing the optimal strategy to show the value of a product to each health plan/payer, circumventing risk, and driving optimal reimbursement. That’s the core theme of this paper based upon the experience and expertise of the D2 team.”

Erhardt points to the impact of bundled payments, accountable care, comparative effectiveness research (CER), evidence-based medicine (EBM) and payments linked to performance. Complex regulatory issues must also be addressed in order to successfully negotiate value based payment models.

“This paradigm shift calls for innovative approaches to commercialization, pricing and reimbursement,” says Erhardt. “Expert legal and business advice are critical for arrangements involving commercial or government payers. Manufacturers must demonstrate flexibility and communicate their understanding and appreciation of stakeholder expectations.”

He emphasizes that while VBC is an “opportunity waiting to happen,” the knowledge, expertise and experience of the D2 team is a key for achieving measurable results.

About D2 Consulting

D2 Consulting is a leading provider of commercialization services to the healthcare and life sciences industries, D2 works across all stakeholders including manufacturers, payers and channel participants to execute strategic business initiatives that ensure successful launch, distribution and reimbursement to maximize market impact and support an ongoing leadership position in the marketplace. Visit http://d2rx.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181017005496/en/

Editor Details

Last Updated: 19-Oct-2018